Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MPWR vs MRNA✓SelectedUSD · MRNAMPWR vs MRNA performance historyLatest closeAs of-11.87%11/20
Stock and ETF performance explorer

MPWR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+112.4%
MRNA return
-27.3%
Excess return
+139.6%
Maximum drawdown
-51.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-11.9%-2.2%-9.7%-11.6%
7D-17.9%-12.7%-5.2%-16.7%
30D-11.0%-20.7%+9.7%-8.9%
3M-12.7%+46.3%-59.0%-16.3%
6M-26.3%+305.2%-331.5%-46.3%
YTD+26.6%+561.2%-534.6%-22.2%
1Y+34.1%+772.1%-738.0%-24.8%
3Y+111.7%+147.0%-35.2%+55.1%
All+112.4%-27.3%+139.6%+91.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling